Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

Eitemau Tebyg

• Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
  gan: Kett, Daniel H, et al.
  Cyhoeddwyd: (2011)
• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by <it>Candida albicans</it>: a multivariate analysis of factors associated with improved outcome
  gan: Reisman Arlene L, et al.
  Cyhoeddwyd: (2011-09-01)
• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
  gan: Reboli, Annette C, et al.
  Cyhoeddwyd: (2011)
• Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia
  gan: Krause, David S., et al.
  Cyhoeddwyd: (2004)
• Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
  gan: Ruhnke, M, et al.
  Cyhoeddwyd: (2011)